These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3540373)

  • 1. [Application of personal computer for interpretation system of clinical pathophysiology in patients with Graves' disease].
    Hashimoto T; Matsubara F; Muramoto S
    Rinsho Byori; 1986 Sep; 34(9):1021-30. PubMed ID: 3540373
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of T3 suppression and TRH stimulation tests in the diagnosis of ophthalmic Graves' disease].
    Tao Y; Song GX
    Zhonghua Yi Xue Za Zhi; 1987 Dec; 67(12):665-7. PubMed ID: 3130158
    [No Abstract]   [Full Text] [Related]  

  • 3. Triiodothyronine suppression tests and TSH-releasing hormone tests before and after I- 131 therapy for Graves' disease.
    Tamai H; Nakagawa T; Takahashi H; Ohsako N; Fukino O; Shinzato R; Suematsu H; Matsuzuka F; Kuma K; Nagataki S
    J Nucl Med; 1980 Mar; 21(3):240-5. PubMed ID: 6892713
    [No Abstract]   [Full Text] [Related]  

  • 4. Is it possible to predict the onset of Graves' disease?
    Amino N
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):589. PubMed ID: 17082799
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis of hyperthyroidism. Statistical evaluation of laboratory and clinical criteria.
    Lamberg BA; Heinonen OP; Viherkoski M; Aro A; Liewendahl K; Kvist G; Laitinen O; Knekt P
    Acta Endocrinol Suppl (Copenh); 1970; 146():1-42. PubMed ID: 4194858
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory examination of the thyroid. 1. In vitro tests.
    Schneider PB
    Postgrad Med; 1974 Aug; 56(2):91-6. PubMed ID: 4136847
    [No Abstract]   [Full Text] [Related]  

  • 7. [Test of inhibition of thyroid uptake of radioiodine by means of triiodothyronine in patients with Basedow's disease in clinical remission].
    Giustina G; Lodeserto A; Valentini F; Cantalamessa L; Vallino F
    Folia Endocrinol; 1965 Jun; 18(3):257-66. PubMed ID: 5898133
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid function during pregnancy in women with past Graves' disease.
    Luton D; Le Gac I; Noel M; Guibourdenche J; Polak M
    BJOG; 2005 Nov; 112(11):1565-7. PubMed ID: 16225580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
    Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of laboratory diagnostics in patient management for Graves' disease.
    Chuma-Bitcon V; Gruson D
    MLO Med Lab Obs; 2016 Jul; 48(7):28, 30, 33. PubMed ID: 27548921
    [No Abstract]   [Full Text] [Related]  

  • 11. Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.
    Glaser NS; Styne DM;
    Pediatrics; 2008 Mar; 121(3):e481-8. PubMed ID: 18267979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of thioredoxin in patients with Graves' disease.
    Kihara M; Kontani K; Yamauchi A; Miyauchi A; Nakamura H; Yodoi J; Yokomise H
    Int J Mol Med; 2005 May; 15(5):795-9. PubMed ID: 15806300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Euthroid Graves' disease].
    Pittman JA; Smitherman TC; Harben GA
    Cas Lek Cesk; 1968; 107(38):1161-5. PubMed ID: 4176202
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease.
    Balázs C; Kiss E
    Acta Microbiol Immunol Hung; 1994; 41(4):451-6. PubMed ID: 7866729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
    Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
    Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer analysis of frequency spectrum of a phonothyreogram.
    Blinowska KJ; Czerminska MA; Chomicki OA; Górowski T
    Med Biol Eng Comput; 1979 Mar; 17(2):207-10. PubMed ID: 312397
    [No Abstract]   [Full Text] [Related]  

  • 18. [Graves' disease].
    Willhauck MJ; Spitzweg C
    MMW Fortschr Med; 2008 Sep; 150(36-37):31-5. PubMed ID: 18988333
    [No Abstract]   [Full Text] [Related]  

  • 19. [Erythrocyte carbonic anhydrase I and zinc concentrations in thyrotoxicosis reflect integrated thyroid hormone levels over the previous few months].
    Yoshida K
    Rinsho Byori; 2007 Jun; 55(6):560-5. PubMed ID: 17657991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.